Atnahs Pharma Us Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ATNAHS PHARMA US, and what generic and branded alternatives to ATNAHS PHARMA US drugs are available?
ATNAHS PHARMA US has five approved drugs.
Drugs and US Patents for Atnahs Pharma Us
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Atnahs Pharma Us | KETOROLAC TROMETHAMINE | ketorolac tromethamine | TABLET;ORAL | 216407-001 | Oct 21, 2022 | AB | RX | No | No | ⤷ Try for Free | ⤷ Try for Free | ||||
Atnahs Pharma Us | EC-NAPROSYN | naproxen | TABLET, DELAYED RELEASE;ORAL | 020067-002 | Oct 14, 1994 | AB | RX | Yes | Yes | ⤷ Try for Free | ⤷ Try for Free | ||||
Atnahs Pharma Us | NAPROSYN | naproxen | TABLET;ORAL | 017581-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try for Free | ⤷ Try for Free | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Atnahs Pharma Us
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Atnahs Pharma Us | NAPROSYN | naproxen | SUSPENSION;ORAL | 018965-001 | Mar 23, 1987 | 4,009,197 | ⤷ Try for Free |
Atnahs Pharma Us | NAPROSYN | naproxen | TABLET;ORAL | 017581-004 | Apr 15, 1982 | 3,904,682 | ⤷ Try for Free |
Atnahs Pharma Us | NAPROSYN | naproxen | TABLET;ORAL | 017581-002 | Approved Prior to Jan 1, 1982 | 3,998,966 | ⤷ Try for Free |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.